APA

Leonetti M., Desvignes C., Bougault I., Souilhac J., Oury-Donat F. & Steinberg R. (20060503). 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission. : Neuroscience.

Chicago

Leonetti M, Desvignes C, Bougault I, Souilhac J, Oury-Donat F and Steinberg R. 20060503. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission. : Neuroscience.

Harvard

Leonetti M., Desvignes C., Bougault I., Souilhac J., Oury-Donat F. and Steinberg R. (20060503). 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission. : Neuroscience.

MLA

Leonetti M, Desvignes C, Bougault I, Souilhac J, Oury-Donat F and Steinberg R. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission. : Neuroscience. 20060503.